Serology of a young man shows HBsAg however HBeAg is negative with normal levels of AST and ALT. He is asymptomatic. What is the next line of management ?
**Core Concept**
The patient is a chronic carrier of hepatitis B virus (HBV) with a low replication status, indicated by the presence of HBsAg and absence of HBeAg. The presence of normal liver enzymes (AST and ALT) suggests that the patient is not experiencing acute liver injury.
**Why the Correct Answer is Right**
In asymptomatic chronic HBV carriers with low replication status, the risk of transmitting the virus to others is low, and the risk of developing liver cirrhosis or hepatocellular carcinoma is also low. Therefore, the patient does not require immediate antiviral treatment. However, regular monitoring of liver enzymes and HBV DNA levels is essential to assess the risk of disease progression. This patient is a good candidate for a "watchful waiting" approach.
**Why Each Wrong Option is Incorrect**
**Option A:** Immediate antiviral treatment is not necessary for asymptomatic chronic HBV carriers with low replication status.
**Option B:** Liver biopsy is not indicated in this patient, as the presence of normal liver enzymes suggests that the liver is not experiencing significant injury.
**Option C:** Interferon-alpha therapy is not a first-line treatment for chronic HBV infection, especially in patients with low replication status.
**Clinical Pearl / High-Yield Fact**
Asymptomatic chronic HBV carriers with low replication status can be safely monitored with regular liver enzyme and HBV DNA level checks, and antiviral treatment can be initiated if there is evidence of disease progression.
**Correct Answer: None of the above. The patient should be placed on regular follow-up for monitoring of liver enzymes and HBV DNA levels.**